Solventum Corporation (SOLV)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 73.63 |
Market Cap | 12.72B |
Revenue (ttm) | 8.24B |
Net Income (ttm) | 519.07M |
EPS (ttm) | 0.38 |
PE Ratio (ttm) | 193.79 |
Forward PE | 12.8 |
Analyst | Hold |
Ask | 73.74 |
Volume | 1,037,453 |
Avg. Volume (20D) | 949,161 |
Open | 73.79 |
Previous Close | 74.02 |
Day's Range | 73.21 - 74.25 |
52-Week Range | 47.16 - 77.17 |
Beta | -0.25 |
About SOLV
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management...
Analyst Forecast
According to 10 analyst ratings, the average rating for SOLV stock is "Hold." The 12-month stock price forecast is $70, which is a decrease of -4.94% from the latest price.